Enzymes are protein catalysts that increase the rate of chemical reactions in biological systems. They do this by lowering the activation energy of reactions, making it easier for substrates to reach the transition state and form products. The substrate binds to the active site of the enzyme, forming an enzyme-substrate complex. This complex undergoes changes that facilitate the reaction, converting the substrate to products. Factors like temperature, pH, substrate and enzyme concentration can affect the rate of enzyme-catalyzed reactions. Enzymes are highly specific and only catalyze certain reactions. They are regulated by inhibitors that bind to the active site and decrease catalytic activity.
2. Enzymes- Biocatalyst
A catalyst is defined as a substance that increase the
velocity or rate of a chemical reaction without itself
undergoing any change in overall process.
3. Definition
Enzymes may be defined as “protein catalysts that
catalyse chemical reactions in biological systems”
Exceptions- Ribozymes(RNA molecules)
Enhance the rates of the corresponding non catalyzed
reaction by factors of at least 10 6
4. Enzymes are proteins that increase the rate of reaction by
lowering the energy of activation
They catalyze nearly all the chemical reactions taking
place in the cells of the body.
Not altered or consumed during reaction.
Reusable
6. Substrate- Reactant on which enzyme acts is known
as a substrate for that enzyme
Enzyme converts Substrate into Products
Enzyme(E)
Amylase(E)
Substrate Product
Starch Glucose
9. Source and distribution
Produced in living cells, but can act outside also
Distributed in cells, organs, fluids , blood
Intracellular distribution related to function of the cell
10. Location Function Examples
Cell membrane Transport Na-K ATPase
Mitochondria Energy TCA, Beta Oxidation
Lysosomes Hydrolysis Peptidases,Glycosidase
Nucleus Genetic information DNA and RNA
polymerase
Cytosol Accessory Pathway Glycolysis,HMP shunt
Microsomes Synthetic FA chain elongation
12. Proenzymes or Zymogens
Activated by proteolysis/ Covalent modification
Eg. Chymotrypsinogen---Chymotrypsin
Isoenzyme- physically distinct form of same enzyme
Different AA sequence, different location, same
function
Eg. Alkaline Phosphatase, LDH
18. 2. Transferases
“Transfer various groups (Other than Hydrogen)”
Transaminase- Transfer of amino group
Methyltransferase- Transfer of one Carbon group
Kinase- Transfer of Phosphate group
21. 3.Hydrolases
These are hydrolytic enzymes which hydrolyse bonds
such as peptide, ester, glycosidic bonds etc by adding a
water molecule.
These enzymes are commonly found in the digestive
secretions and lysosomes
DIGESTIVE ENZYMES…
22. They hydrolyse carbohydrates, lipids, proteins
Examples are amylase, lipase, pepsin, ribonuclease,
sucrase, lactase, maltase
37. Metal ions as a Cofactor
• Metal ions tightly bound to enzyme protein
• Metal ions cant be separated without
breakdown of enzyme
• Eg. Cytochrome Oxidase ( Fe++ and Cu++ )
• Carbonic Anhydrase ( Zn++)
Metallo
Enzyme
• Metal ions loosely bound to enzyme protein
• Metal ions easily separated without
breakdown of enzyme
• Eg Hexokinase ( Mg++)
• Amylase (Cl-)
Metal
Activated
enzyne
38. Coenzyme
“ Non protein, dialysable, low molecular and organic
substance associated with enzyme activity is known
as Co enzyme”
43. Class-2 ( other than H+)
Co Enzymes Group Transfer
TPP Hydroxymethyl
Biotin CO2
PLP Aminogroup
Co A Acyl group
TetraHydro Folate One Carbon group
ATP phosphate
50. Questions
1) Difference between Synthase and
Synthatase(3)
2) Vitamine derivative helps in
transfer of amino group(3)
3) Cleave the bond without help of
water(7)
4) Property of active site(11)
5) Enzyme with group specificity(10)
6) Non protein part of enzyme(8)
7) Metal require for cytochrome
oxidase(4)
8) Coenzyme of class 1(3)
9) I activate Xanthine Oxidase(10)
10) I am the current topic which you
are learning (6)
51. Mechanism of Action of Enzymes
“Enzymes increases reaction rate by
decreasing the Activation energy”
Enzyme-Substrate Interactions:
Formation of Enzyme substrate
complex by:
Lock-and-Key Model
Induced Fit Model
Substrain strain Theory
52. Lowering the activation
energy
Activation energy: energy
required to reach the
transition state
Transition state: state in
which there is a high
probability that a chemical
bond will be made or broken
to form a product
No change in ∆G and Keq of
reaction
55. Enzyme Catalyzed Reactions
• When a substrate (S) fits properly in an active site, an
enzyme-substrate (ES) complex is formed:
E + S ⇄ ES
• Within the active site of the ES complex, the reaction
occurs to convert substrate to product (P):
ES → E + P
• The products are then released, allowing another
substrate molecule to bind the enzyme
- this cycle can be repeated millions (or even more) times
per minute
• The overall reaction for the conversion of substrate to
product can be written as follows:
E + S ⇄ ES → E + P
64. Rate of Reaction(Velocity)
Defined as a rate of change from substrate to
product per unit of time ( V)
Maximum velocity ( Vmax) – 100 % enzyme
molecules binds to substrates
½ Vmax – 50%
66. In the initial part of the curve, the number of
times the velocity increases when the
temperature rises by 10°C is known as the
temperature coefficient (Q10) of the enzyme
For most of the enzymes, the temperature
coefficient is two
• This means that the velocity is doubled when
the temperatures rises by 10°C
67. Effect of pH
• Enzymes are proteins
• Share the same property
• Very High or Low pH
away from optimum pH
may denature an enzyme
70. Substrate Concentration and Reaction Rate
• The rate of reaction increases as substrate
concentration increases (at constant enzyme
concentration)
• Maximum activity occurs when the enzyme is
saturated (when all enzymes are binding substrate)
71.
72. Km(Michaelis Menten
Constant)
“The concentration of substrate at which the rate of
reaction is equal to the half of the maximum rate of
reaction”
Represents the affinity of an enzyme towards an
substrate
73.
74. Km and Affinity
Hexokinase (Km = 0.05 mmol/L) for glucose
Glucokinase (Km = 10 mmol/L) for glucose
Higher the Km lower the Affinity
Lower the Km Higher the Affinity
75. The relationship between the velocity of the
reaction and the substrate concentration can be
expressed by Michaelis-Menten equation, which is:
[ ]
[ ]
maxV Sv
Km S
=
+
.
76. When the substrate concentration is very low, the
sum of Km and [S] is nearly equal to Km as [S] is
negligible
Therefore, the equation may be rewritten as:
[ ]maxV S
v
Km
= .
Since both Vmax and Km are constant,
V [S]
[ ]
[ ]
maxV Sv
Km S
=
+
.
77. When the substrate concentration is very high,
the sum of Km and [S] is nearly equal to [S] as Km is
relatively negligible
Therefore, the equation may be rewritten as:
or = Vmax
[ ]
[ ]
maxV Sv
S
= .
v
[ ]
[ ]
maxV Sv
Km S
=
+
.
78. When the substrate concentration is exactly
equal to Km, the sum of Km and [S] may be taken
as 2 [S]
The equation may be rewritten as:
Thus, when the substrate concentration is equal
to Km, the velocity is half of Vmax
=
[ ]
[ ]
max maxV S V
v
2 S 2
= .[ ]
[ ]
maxV Sv
Km S
=
+
.
79.
80. Substrate Concentration and Reaction Rate
• The rate of reaction increases as substrate
concentration increases (at constant enzyme
concentration)
• Maximum activity occurs when the enzyme is
saturated (when all enzymes are binding substrate)
81.
82.
83. Features of Km
Definition
50% of Enzyme molecules are occupied
Signature of an enzyme, for each substrate
Not dependent on enzyme concentration
Denotes Affinity
89. Competitive Inhibition
• competes with the for active site of
• Inhibitor is a structural analogue of the substrate
• Is concentration dependent ; reversible
I S E
90.
91. E + S E-S complex E + P
E + I E-I Complex
+
Inhibitor
Product
92.
93.
94. Some competitive inhibitors used as drugs:
1. Amethopterin, Methotrexate (Folic Acid)
2. Allopurinol (Hypoxanthine)
3. Statins (HMG CoA)
4. Sulfonamide ( PABA )
5. Isoniazid ( Pyridoxal- Vitamin B6)
95. H N2 N
N
|
OH
1
2
3
4
N
5
6
7
8
N
9 10
CH — N —2 — C — N — CH
| |
H COOH
COOH
|
CH2
|
CH2
|
O
||
H
|
Pteridine para-Amino-
benzoic acid
Glutamic
acid
Pteroylgutamic acid (folic acid)H N2 N
N
|
OH
1
2
3
4
N
5
6
7
8
N
9 10
CH — N —2 — C — N — CH
| |
H COOH
COOH
|
CH2
|
CH2
|
O
||
H
|
Pteridine para-Amino-
benzoic acid
Glutamic
acid
C 3
Folic acid
Amethopterin
Amethopterin and aminopterin
96. Amethopterin and aminopterin (Contd.)
These are competitive inhibitors of dihydrofolate
reductase
Dihydrofolate + NADPH + H
+
Tetrahydrofolate + NADP
+
Dihydrofolate
reductase
4
Folate + NADPH + H
Dihydrofolate
reductase
4
+
97. Amethopterin and aminopterin (Contd.)
This reaction is important in the synthesis of purine
and thymine nucleotides
Inhibition of this reaction decreases the availability of
nucleotides for DNA synthesis, and inhibits cell division
Therefore, amethopterin and aminopterin are used as
anti-cancer drugs to suppress the unregulated cell division that
occurs in cancer
98. Allopurinol
Allopurinol is a structural analogue of
hypoxanthine
It is a competitive inhibitor of xanthine oxidase
N
HN
O
||
C
C
CHC
N
H
H
C
N
N
HN
O
||
C
C
CHC
N
H
N
CH
Hypoxanthine Allopurinol
99. Allopurinol (Contd.)
Xanthine oxidase converts hypoxanthine into
xanthine, and xanthine into uric acid
In gout, which results from overproduction of uric
acid, allopurinol is used to inhibit the formation
of uric acid
Hypoxanthine
Xanthine
oxidase
Uric acidXanthine
Xanthine
oxidase
102. Let us Revise……
• Definition and types
Substrate & inhibitor have structural similarity
Compete for same active site of enzyme
Reversible
Km and Vmax remains same
Reversed by increasing substrate conc.
Competitive inhibition
104. NonCompetitive Inhibition
• does not competes with the for active site of
• Inhibitor is not a structural analogue of the substrate
• Is not concentration dependent ; Irreversible
I S E
108. Examples of Non competitive inhibition includes use of
Disulfiram in treatment of Alcoholism.
Alcohol -------> Acetaldehyde ------->Acetic Acid
Alcohol
dehydrogenase
Acetaldehyde
dehydrogenase
109. COMPETITIVE NON COMPETITIVE
Acting on Active site May or May not
Structure of inhibitor Substrate analogue Not related
Inhibition Reversible Irreversible
Excess Substrate Relieved Inhibition No effect
Km Increased No change
Vmax No change Decreased
Significance Drug action Toxicological
110. Allosteric Regulation
Allosteric enzymes have two binding sites:
Catalytic site- Substrate binds
Allosteric site- Allosteric modulator binds
Controls the key enzymes of Metabolic pathway
115. Covalent Modification
Addition or removal of a group may activate or
deactivate an enzyme
Under hormonal influence
Phosphorylation/ Dephosphorylation
116.
117. ISO ENZYMES
Multiple form of an Enzyme that carries out same
reaction
Different in amino acid sequence
Difference in properties such as temp, pH,Km and
effect of inhibitor etc.
130. • CK
• AST
• Aldolase
Muscular
disease
• Alkaline PhosphataseBone
• Acid phosphatase
• Prostate Specific AntigenProstate
131. This enzyme catalyses the interconversion of
pyruvate and lactate
Its tissue distribution is very wide
However, its concentration is much higher in
myocardium, muscles and liver than in other
tissues
132. Therefore, plasma LDH rises in myocardial
infarction, viral hepatitis and muscle injuries
In myocardial infarction, the rise begins 24 hours
after the episode of infarction, the peak value is
reached in about three days, and the level returns to
normal in about a week
133. The two most important transaminases are
glutamate oxaloacetate transaminase (GOT)
and glutamate pyruvate transaminase (GPT)
These are also known as aspartate
aminotransferase (AST) and alanine
aminotransferase (ALT) respectively
These are present in high concentrations in
myocardium, liver and muscles
134. Therefore, their plasma levels are raised in
myocardial infarction, viral hepatitis and
muscle injuries
Concentration of SGOT is higher than that of
SGPT in myocardium while the situation is reverse in
liver
Therefore, the rise in plasma SGOT is more
pronounced in myocardial infarction and that in
SGPT is more pronounced in viral hepatitis
135. It is also known as creatine phosphokinase
(CPK), and catalyses the following reaction:
CK is present in myocardium, muscles and brain
Creatine + ATP Creatine ~ P + ADP
136. Plasma CK rises in myocardial infarction,
myopathies and muscle injuries
Plasma CK is a more specific and early indicator
of myocardial infarction than LDH and GOT
It begins to rise within 3-6 hours of occurrence of
infarction, reaches its peak in 24 hours, and returns to
normal in about three days
137. Marker Onset Peak Duration
CK MB 3-6 Hr 18-24 Hr 36-72 Hr
Troponins 4-10 Hr 18-24 Hr 8-14 Days
LDH 6-12 Hr 24-48Hr 6-8 Days
AST 24-36 Hr 4-5 Days 10-12 Days
Myoglobin 1-4 Hr 6-7 Hr 24 Hrs
138. 1 2 3 4 5 6 70
Enzyme
level
Upper limit
of normal
Days
CK GOT LDH
139. Apart from LDH, GOT and CK, some non-enzyme
proteins are also released from myocardium after
myocardial infarction, and are useful in diagnosis
Begins to
rise in
Reaches
peak in
Returns to
normal in
Specificity
Myoglobin 1-3 hrs 4-6 hs 18-24 hrs Low
Cardiac troponin T 4-6 hrs 18-36 hs 5-15days Low
Cardiac troponin I 4-6 hrs 12-24 hs 5-10days High
140. This enzyme catalyses the transfer of the
gamma-glutamyl residue of glutathione to
other substrates
Its plasma level increases in most of the liver
diseases, and is an early indicator of alcoholic
hepatitis
141. This is a group of enzymes that hydrolyse
organic phosphate esters at an alkaline pH
ALP is released in circulation mainly from
bones and liver
Smaller amounts come from intestines and
placenta
Liver excretes ALP in bile
142. The maximum elevation of plasma ALP occurs in
obstructive jaundice
Smaller elevations occur in viral
hepatitis, rickets,hyperparathyroidism,
osteosarcoma, bony metastases etc
143. This enzyme hydrolyses organic phosphate
esters at an acidic pH
The main source of ACP is the prostate gland
Plasma ACP is elevated in metastatic
carcinoma of prostate
144. This is a digestive enzyme, synthesised in the
pancreas and the parotid gland
Sharp elevation of plasma amylase occurs in
acute pancreatitis
A smaller elevation occurs in acute parotitis
145. This lipolytic enzyme is released into circulation
from the pancreas
Plasma lipase rises in acute pancreatitis